Chris Shumate

Chris Shumate is currently the CEO of Etaluma, Inc., where Chris has simplified fluorescence microscopy through next-generation technology. Throughout their career, Chris has held various key positions in companies such as MDS AT, Blueshift Biotechnologies, and CytoPrint. With a strong background in chemistry and analytical chemistry, Chris has also worked in roles involving business development and product management in the life sciences industry.